 |
PDBsum entry 3vhk
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
A back-To-Front fragment-Based drug design search strategy targeting the dfg-Out pocket of protein tyrosine kinases.
|
 |
|
Authors
|
 |
H.Iwata,
H.Oki,
K.Okada,
T.Takagi,
M.Tawada,
Y.Miyazaki,
S.Imamura,
A.Hori,
J.D.Lawson,
M.S.Hixon,
H.Kimura,
H.Miki.
|
 |
|
Ref.
|
 |
Acs Med Chem Lett, 2012,
3,
342-346.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We present a straightforward process for the discovery of novel back
pocket-binding fragment molecules against protein tyrosine kinases. The approach
begins by screening against the nonphosphorylated target kinase with subsequent
counterscreening of hits against the phosphorylated enzyme. Back pocket-binding
fragments are inactive against the phosphorylated kinase. Fragment molecules are
of insufficient size to span both regions of the ATP binding pocket; thus, the
outcome is binary (back pocket-binding or hinge-binding). Next, fragments with
the appropriate binding profile are assayed in combination with a known
hinge-binding fragment and subsequently with a known back pocket-binding
fragment. Confirmation of back pocket-binding by Yonetani-Theorell plot analysis
progresses candidate fragments to crystallization trials. The method is
exemplified by a fragment screening campaign against vascular endothelial growth
factor receptor 2, and a novel back pocket-binding fragment is presented.
|
 |
|
|
|
|
 |